EP3300721
PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
:
EP einkaleyfi: Þýðing ekki lögð inn:
18.11.2004:
6.3.2019:
17196501.5
:
17.11.2024
:
PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
18.11.2004
6.3.2019
:
Novo Nordisk A/S:
Novo Allé, 2880, Bagsværd, DK
:
Bonde, Claude:
Bagsværd, DK
:
Engelund, Dorthe Kot:
Bagsværd, DK
:
Pedersen, Tina Bjeldskov:
Bagsværd, DK
:
200301719:
20.11.2003:
DK
:
A61K 9/00, A61K 38/26, A61K 38/28, A61K 47/10, A61K 47/18, A61K 47/20, A61K 47/26